journal article·2023-04-25Open access

Enhanced Nanobubble Formation: Gold Nanoparticle Conjugation to Qβ Virus-like Particles

Perouza Parsamian, Yaning Liu, Chen Xie, Zhuo Chen, Peiyuan Kang, Yalini H. Wijesundara, Noora M. Al-Kharji, Ryanne Nicole Ehrman, Orikeda Trashi, Jaona Randrianalisoa, Xiangyu Zhu, Matthew D’Souza, Lucas Anderson Wilson, Moon J. Kim, Zhenpeng Qin, Jeremiah J. Gassensmith

ACS Nano· Volume 17· Issue 8

Abstract

Plasmonic gold nanostructures are a prevalent tool in modern hypersensitive analytical techniques such as photoablation, bioimaging, and biosensing. Recent studies have shown that gold nanostructures generate transient nanobubbles through localized heating and have been found in various biomedical applications. However, the current method of plasmonic nanoparticle cavitation events has several disadvantages, specifically including small metal nanostructures (≤10 nm) which lack size control, tuneability, and tissue localization by use of ultrashort pulses (ns, ps) and high-energy lasers which can result in tissue and cellular damage. This research investigates a method to immobilize sub-10 nm AuNPs (3.5 and 5 nm) onto a chemically modified thiol-rich surface of Qβ virus-like particles. These findings demonstrate that the multivalent display of sub-10 nm gold nanoparticles (AuNPs) caused a profound and disproportionate increase in photocavitation by upward of 5-7-fold and significantly lowered the laser fluency by 4-fold when compared to individual sub-10 nm AuNPs. Furthermore, computational modeling showed that the cooling time of QβAuNP scaffolds is significantly extended than that of individual AuNPs, proving greater control of laser fluency and nanobubble generation as seen in the experimental data. Ultimately, these findings showed how QβAuNP composites are more effective at nanobubble generation than current methods of plasmonic nanoparticle cavitation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Minerals Flotation and Separation Techniques · Characterization and Applications of Magnetic Nanoparticles · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut de Thermique, Mécanique, Matériaux − ITheMM EA 7548 Université de Reims Champagne-Ardenne, Campus Moulin de la Housse, F-51687 Reims, France

Funding

Welch Foundation · Division of Materials Research

References (58)

Show source-provided references
1. 10.3390/molecules2501011210.3390/molecules25010112 ↗
2. 10.1088/1361-648X/aa60f310.1088/1361-648X/aa60f3 ↗
3. 10.1007/s13404-019-00252-210.1007/s13404-019-00252-2 ↗
4. 10.1038/lsa.2012.1410.1038/lsa.2012.14 ↗
5. 10.1039/C7CC09613E10.1039/C7CC09613E ↗
6. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
7. 10.3390/polym1009096110.3390/polym10090961 ↗
8. 10.1007/s11426-009-0247-010.1007/s11426-009-0247-0 ↗
9. 10.1016/j.biomaterials.2010.06.03110.1016/j.biomaterials.2010.06.031 ↗
10. 10.1002/smll.20170084110.1002/smll.201700841 ↗
11. 10.1039/C1CS15184C10.1039/C1CS15184C ↗
12. 10.1021/acs.nanolett.1c0299610.1021/acs.nanolett.1c02996 ↗
13. Li, X.; Cai, Q.; Wilson, B. A.; Fan, H.; Giannotta, M.; Bachoo, R.; Qin, Z., Calcium-Mediated Modulation of Blood-Brain Barrier Permeability by Laser Stimulation of Endothelial-Targeted Nanoparticles. bioRxiv, 2022.06.02.494541, ver. 1, 2022. https://www.biorxiv.org/content/10.1101/2022.06.02.494541v1 (accessed 2023-02-27).
14. 10.1039/b809585j10.1039/b809585j ↗
15. 10.1039/c0cc03033c10.1039/c0cc03033c ↗
16. 10.1038/nmat249610.1038/nmat2496 ↗
17. 10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A ↗
18. 10.1002/smll.20140151210.1002/smll.201401512 ↗
19. 10.1002/smll.20130139310.1002/smll.201301393 ↗
20. 10.1021/nn100022210.1021/nn1000222 ↗
21. 10.1088/0957-4484/21/8/08510210.1088/0957-4484/21/8/085102 ↗
22. 10.1038/nnano.2015.34310.1038/nnano.2015.343 ↗
23. 10.1016/j.jss.2010.10.03910.1016/j.jss.2010.10.039 ↗
24. 10.1038/nm.348410.1038/nm.3484 ↗
25. 10.7150/thno.511610.7150/thno.5116 ↗
26. 10.1021/la501536210.1021/la5015362 ↗
27. 10.1364/BOE.2.00029110.1364/BOE.2.000291 ↗
28. 10.7150/thno.449410.7150/thno.4494 ↗
29. 10.1002/adma.20110355010.1002/adma.201103550 ↗
30. 10.1016/j.mtchem.2022.10080810.1016/j.mtchem.2022.100808 ↗
31. 10.1002/wnan.137910.1002/wnan.1379 ↗
32. 10.1002/btm2.1004910.1002/btm2.10049 ↗
33. 10.1038/s41598-021-94561-210.1038/s41598-021-94561-2 ↗
34. 10.1007/978-1-4939-7893-9_810.1007/978-1-4939-7893-9_8 ↗
35. 10.1021/acsami.8b2050410.1021/acsami.8b20504 ↗
36. 10.1021/acs.bioconjchem.0c0019010.1021/acs.bioconjchem.0c00190 ↗
37. 10.1021/jacs.1c0509010.1021/jacs.1c05090 ↗
38. 10.1021/jacs.8b1044610.1021/jacs.8b10446 ↗
39. 10.1016/S0969-2126(96)00060-310.1016/S0969-2126(96)00060-3 ↗
40. 10.1002/cbic.20100012510.1002/cbic.201000125 ↗
41. 10.1021/bm200983k10.1021/bm200983k ↗
42. 10.1002/cbic.20110046910.1002/cbic.201100469 ↗
43. 10.1021/acs.bioconjchem.7b0030510.1021/acs.bioconjchem.7b00305 ↗
44. 10.1021/acs.molpharmaceut.8b0034810.1021/acs.molpharmaceut.8b00348 ↗
45. 10.1039/C9NR09816J10.1039/C9NR09816J ↗
46. Benjamin C. · 2020 · 15310.1016/B978-0-12-816662-8.00011-4 ↗
47. 10.1039/C9SC05510J10.1039/C9SC05510J ↗
48. 10.1016/j.virol.2022.10.00810.1016/j.virol.2022.10.008 ↗
49. 10.1115/1.405319610.1115/1.4053196 ↗
50. 10.1002/adfm.20170527210.1002/adfm.201705272 ↗
51. 10.3389/fchem.2019.0016710.3389/fchem.2019.00167 ↗
52. 10.1002/smll.20100013410.1002/smll.201000134 ↗
53. 10.1021/acs.chemmater.5b0440610.1021/acs.chemmater.5b04406 ↗
54. 10.1038/srep2983610.1038/srep29836 ↗
55. 10.1007/s11004-009-9257-x10.1007/s11004-009-9257-x ↗
56. 10.1021/acsnano.5b0662310.1021/acsnano.5b06623 ↗
57. 10.1115/1.404901710.1115/1.4049017 ↗
58. 10.4236/jbnb.2011.2100710.4236/jbnb.2011.21007 ↗